
Episode: 161 - Tomorrow Health CEO Vijay Kedar on the Coordination and Delivery of High-Quality and High-Efficiency Home Healthcare in Today’s Medical Landscape
03/21/23 • 30 min
Vijay Kedar, co-founder and CEO of Tomorrow Health, was raised in a family of physicians, often joking that he was “pre-med coming out of the womb.” However, it wasn’t until he took on managing his mother's care through stage III colorectal cancer and acute respiratory distress syndrome that the idea for Tomorrow Health was born. In this episode, Kedar speaks with host Steve Krupa about using technology to coordinate high-quality home-based care for patients and families who find securing such care increasingly difficult to navigate.
Kedar also discusses how home-based care improves health outcomes, alleviates the administrative and healthcare burden for providers, and is often the most economical option for patients requiring long-term treatment. He says, “Treating a patient with the same conditions at home can be one-tenth the cost of doing so in a hospital-based setting and one-third the cost of doing so in a post-acute setting like a skilled nursing facility.” Kedar goes on to outline how Tomorrow Health’s launch during the pandemic essentially changed how home-based care was ordered, delivered, and purchased to meet an ever-growing demand.
Links from this episode:
HealthEdge
Tomorrow Health
Vijay Kedar’s direct email
Vijay Kedar, co-founder and CEO of Tomorrow Health, was raised in a family of physicians, often joking that he was “pre-med coming out of the womb.” However, it wasn’t until he took on managing his mother's care through stage III colorectal cancer and acute respiratory distress syndrome that the idea for Tomorrow Health was born. In this episode, Kedar speaks with host Steve Krupa about using technology to coordinate high-quality home-based care for patients and families who find securing such care increasingly difficult to navigate.
Kedar also discusses how home-based care improves health outcomes, alleviates the administrative and healthcare burden for providers, and is often the most economical option for patients requiring long-term treatment. He says, “Treating a patient with the same conditions at home can be one-tenth the cost of doing so in a hospital-based setting and one-third the cost of doing so in a post-acute setting like a skilled nursing facility.” Kedar goes on to outline how Tomorrow Health’s launch during the pandemic essentially changed how home-based care was ordered, delivered, and purchased to meet an ever-growing demand.
Links from this episode:
HealthEdge
Tomorrow Health
Vijay Kedar’s direct email
Previous Episode

Episode: 160 - A. J. Loiacono on Capital Rx’s Mission to Remodel the American Drug Pricing System as a Tech-Based Pharmacy Benefit Manager
AJ Loiacono’s experience in supply chain consulting for pharmaceutical manufacturing afforded him a world-class education in supply chain logistics, drug pricing, and software implementation. However, it wasn’t until he worked with healthcare payers that he realized the glaring problems in the U.S. drug pricing system and that pharmacy benefit managers retained much of the control and profit. He says, “The reason why our drug pricing is the way it is today... is because no one has either had the resource, bravery, or perseverance to stand up and say, ‘This is what’s wrong, and we’re going to fix it instead of profiting off of the system.’”
Looking to disrupt the status quo, Loiacono founded Capital Rx. As one of the fastest growing healthtech companies in America, Capital Rx reconstructs prescription pricing and puts savings back in the patient’s hands. Loiacono speaks with host Steve Krupa about his desire to simplify drug pricing and increase transparency, how Capital Rx’s novel cloud-native enterprise pharmacy platform, JUDI, reduces labor costs by up to 80%, how they maintain a 99.5% retention rate with their clients, and why their books have demonstrated a negative drug trend for the past three years.
Links from this episode:
HealthEdge
Capital Rx
JUDI Enterprise Pharmacy Platform
Capital Rx Facebook
Next Episode

Episode: 162 - Creating Market Pathways for Effective, Validated Digital Therapeutics
Kamal Jethwani began his medical training in India and soon found himself more intrigued by solving of the administrative issues around care delivery. This interest came to a head when he found himself on the front lines of crisis response when his 10-bed emergency department received—and treated—1,700 patients in 72 hours. Afterward, Jethwani realized that there was a whole field of medicine focused on the design of care delivery, he told Breaking Health host Steve Krupa. He knew he had found his focus. After coming to Harvard to earn a master's in public health and finish his medical training, Jethwani worked closely with digital health tools to improve care for patients. He launched Decimal.health during the pandemic to solve the administrative issues around connecting both patients and providers to evidence-based, valid, repeatable, reliable digital health tools.
Links from this episode:
HealthEdge
Decimal.health
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/breaking-health-285538/episode-161-tomorrow-health-ceo-vijay-kedar-on-the-coordination-and-de-36335966"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to episode: 161 - tomorrow health ceo vijay kedar on the coordination and delivery of high-quality and high-efficiency home healthcare in today’s medical landscape on goodpods" style="width: 225px" /> </a>
Copy